| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2464111C Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/07/2013 | WO2013033133A1 Use of organic compound for the treatment of noonan syndrome |
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031935A1 Stable pharmaceutical composition |
| 03/07/2013 | WO2013031931A1 Chemokine receptor activity regulator |
| 03/07/2013 | WO2013031930A1 Imine derivative |
| 03/07/2013 | WO2013031922A1 Pyrazole compound and use thereof for medical purposes |
| 03/07/2013 | WO2013031749A1 Lactic acid bacteria for promoting physical activity |
| 03/07/2013 | WO2013031620A1 Osteogenesis promoter and use thereof |
| 03/07/2013 | WO2013031403A1 Skin-lightening agent |
| 03/07/2013 | WO2013031003A1 Dna repair accelerator and dna damage suppressant |
| 03/07/2013 | WO2012169827A3 Composition for eyelash growth |
| 03/07/2013 | US20130059844 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/07/2013 | US20130059008 Drying methods for tuning microparticle properties |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058866 N-pyrazole a2a receptor agonists |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2845571A1 Use of organic compound for the treatment of noonan syndrome |
| 03/07/2013 | CA2845127A1 Pyrazole compound and pharmaceutical use thereof |
| 03/06/2013 | EP2565269A1 High-purity soluble thrombomodulin and method for producing same |
| 03/06/2013 | EP2565194A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 03/06/2013 | EP2565192A1 Anticancer agent |
| 03/06/2013 | EP2565190A1 Tetrahydrobenzothiophene compound |
| 03/06/2013 | EP2565182A1 Novel amide derivative and use thereof as medicine |
| 03/06/2013 | EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/06/2013 | EP2564849A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 03/06/2013 | EP2563785A1 Compounds as agonists of s1p1 receptors |
| 03/06/2013 | EP2563405A1 Selective integrin inhibitors |
| 03/06/2013 | EP2563370A1 Use of a composition containing phospholipids and glycyrrhizinic acid for removing subcutaneous fat accumulations by means of subcutaneous lipolysis |
| 03/06/2013 | CN102959075A Bifidobacterium having activity of reducing amount of intestinal putrefacted substance |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102949689A Traditional Chinese medicine preparation for treating spontaneous perspiration and leaking sweat |
| 03/06/2013 | CN102949381A Application of ethanol in drug treating acute decompression sickness |
| 03/06/2013 | CN102525910B Process for preparing penehyclidine hydrochloride injection |
| 03/06/2013 | CN102046201B Inhibitor of analgesic tolerance |
| 03/06/2013 | CN101817833B DPP-IV inhibitor |
| 03/06/2013 | CN101679273B 1-substituted tetrahydroisoquinoline compound |
| 03/06/2013 | CN101443004B Formulations and methods for vascular permeability-related diseases or conditions |
| 03/05/2013 | US8389747 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 03/05/2013 | US8389721 Solubilized topoisomerase poisons |
| 03/05/2013 | US8389496 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8389043 Preparation for restenosis prevention |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 03/05/2013 | US8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
| 03/05/2013 | US8388966 Combination treatment of pancreatic cancer |
| 03/05/2013 | US8388943 Multipotent stem cells from peripheral tissues and uses thereof |
| 03/05/2013 | CA2711655C Condensed aminodihydrothiazine derivative |
| 02/28/2013 | WO2013029034A1 Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
| 02/28/2013 | WO2013028501A1 Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
| 02/28/2013 | WO2013027835A1 Method for producing optically active naphthalene compound |
| 02/28/2013 | WO2013027801A1 Fused heterocyclic derivative and pharmaceutical use thereof |
| 02/28/2013 | WO2013027794A1 Novel compound and use thereof as pde10 inhibitor |
| 02/28/2013 | US20130053449 Method for inhibiting histone gene transcription and expression |
| 02/28/2013 | US20130053436 Compounds, compositions and methods |
| 02/28/2013 | US20130053417 Cetp activity inhibitors |
| 02/28/2013 | US20130053360 Controlled release and taste masking oral pharmaceutical composition |
| 02/28/2013 | US20130053329 Methods of inhibiting apoptosis or inflammation in a mammal by administering an isolated bcl protein |
| 02/28/2013 | US20130053319 Chemokine derived peptides and uses for chronic wound and angiogenesis inhibition treatments |
| 02/28/2013 | US20130052271 Compositions and Methods for Treating Pain |
| 02/28/2013 | US20130052251 Composition and method for treating nosebleeds |
| 02/28/2013 | US20130052189 Method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities |
| 02/28/2013 | CA2846416A1 Tripartite bioactive composition providing anti-oxidant and anti-inflammatory effects with immune system and stem cell production enhancement |
| 02/28/2013 | CA2845691A1 Liposome comprising at least one cholesterol derivative |
| 02/27/2013 | EP2562257A1 Method for stabilizing functional nucleic acids |
| 02/27/2013 | EP2562160A1 Therapeutic agent or preventive agent for urine collection disorder |
| 02/27/2013 | EP2561879A1 Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2561869A1 Skin collagen production promoter |
| 02/27/2013 | EP2560942A1 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis |
| 02/27/2013 | CN1886385B Crystals of phenylalanine derivatives and production methods thereof |
| 02/27/2013 | CN102947326A Ccn3 peptides and analogs thereof for therapeutic use |
| 02/27/2013 | CN102947313A Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes |
| 02/27/2013 | CN102946898A Agent for reducing acetaldehyde in oral cavity |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942631A Humanized anti-cmet antagonists |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940149A Poultry traditional Chinese medicine feed additive |
| 02/27/2013 | CN101977600B Protopanaxadiol-type ginsenoside compositions and uses thereof |
| 02/27/2013 | CN101959532B Pharmaceutical composition for transnasal administration |
| 02/27/2013 | CN101798317B N-substituted aminothiazole morphinan compound and preparation method and applications thereof |
| 02/27/2013 | CN101732467B Application of Chinese medicinal composition in preparation of medicament for treating purulent pleurisy |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/27/2013 | CN101475513B Raf and HDAC small molecular double inhibitor, and preparation and use thereof |
| 02/26/2013 | US8383158 Methods and compositions to treat myocardial conditions |
| 02/26/2013 | US8383155 Swellable dosage form comprising gellan gum |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024763A1 Production method for nucleic acid aptamer |
| 02/21/2013 | WO2013024589A1 Prophylactic agent and/or therapeutic agent for sepsis |
| 02/21/2013 | WO2013024582A1 Mphosph1 peptides and vaccines including the same |